Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
| Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
|---|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 | 0 |
| % | 0 | 0 | 0 | 0 | 0 |
The Captial Market (CapitalMarket.com) rating for Tijaria Polypipes IPO is 15. Their analysis recommends Do Not Subscribe for the IPO.
| Reviewer | Rating Score | Rating |
|---|---|---|
| Capital Market | 15 | Do Not Subscribe |
[Dilip Davda] Avoid. For 2010-11 it posted net profit of Rs. 6.90 crore on a turnover of Rs. 118.60 crore that gives EPS of Rs. 2.80 on the post IPO equity translating in P/E of 21 plus against its peer that quotes around 6 P/E and more that 2 P/BV. Read detail review...
Tijaria Polypipes IPO Reviews, analysis and views by popular members. Read Tijaria Polypipes Ltd. IPO reviews by retail investors to find recommended ipo to buy.
| Review By | Apply | May Apply | Neutral | Avoid |
|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 |
| % | 0.00 | 0.00 | 0.00 | 0.00 |
| Member | Review |
|---|---|
| No recommendation found. Be the first to post the recommendation. | |
Note:
RHP